17.36
price down icon3.45%   -0.62
after-market After Hours: 17.37 0.01 +0.06%
loading

Relay Therapeutics Inc Stock (RLAY) Forecast

The Relay Therapeutics Inc (RLAY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $16.98, representing a -2.18% decrease from the current price of $17.36. The highest analyst price target is $21.44, and the lowest is $12.53.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RLAY Price Target
Average 10.91 (-37.16% Downside)
loading

Is Relay Therapeutics Inc (RLAY) A Buy Now?

Oscillators
Name Value Action
RSI(14) 41.23 Neutral
STOCH(9,6) 37.58 Neutral
STOCHRSI(14) 18.14 Buy
MACD(12,26) -0.2982 Sell
ADX(14) 18.57 Neutral
William %R -81.37 Buy
CCI(14) -71.09 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
18.22
Sell
18.03
Sell
MA20
18.29
Sell
18.28
Sell
MA50
19.01
Sell
18.46
Sell
MA100
18.07
Sell
17.49
Sell
MA200
14.35
Buy
14.76
Buy
Buy: 2 Sell: 8 Neutral: 0
Summary: Sell
According to our latest analysis, RLAY could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on RLAY, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 41.23 indicates that RLAY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 37.58 indicates that RLAY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.14 indicates that RLAY is oversold. This suggests that RLAY price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 18.57 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -71.09 indicates that RLAY is still oversold but not to an extreme extent.

Long-term RLAY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Relay Therapeutics Inc financial reports and earnings history, Relay Therapeutics Inc (RLAY) stock could reach $4.9485 by 2030, $29.39 by 2040 and $46.00 by 2050. See the projected annual prices until 2050 of the Relay Therapeutics Inc stock below:

  • Relay Therapeutics Inc (RLAY) is expected to reach an average price of $16.04 in 2035, with a high prediction of $15.33 and a low estimate of $14.46. This indicates an $-7.60% rise from the last recorded price of $17.36.
  • Relay Therapeutics Inc (RLAY) stock is projected to chart a bullish course in 2040, with an average price target of $28.09, representing an $61.81% surge from its current level. The forecast ranges from a conservative $28.89 to a sky-high $29.39.
  • Our analysts predict Relay Therapeutics Inc (RLAY) to jump 125.79% by 2045, soaring from $36.33 to an average price of $39.20, potentially reaching $38.62. While $36.33 is the low estimate, the potential upside is significant.
  • Relay Therapeutics Inc (RLAY) stock is expected to climb by 2050, reaching an average of $48.89, a $181.65% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.00 and $46.90, respectively, highlighting the market's uncertainty.

Relay Therapeutics Inc Stock (RLAY) Year by Year Forecast

Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2026

The predicted value for Relay Therapeutics Inc (RLAY) in 2026 is set at an average of $14.26. Estimates vary from a peak of $21.51 to a trough of $7.01, indicating an -17.86% surge from the present price of $17.36.
Month Average Low High Change from today's price
November, 2026 $13.81 $12.53 $21.44 -20.48%
December, 2026 $13.31 $11.20 $15.91 -23.34%

Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Relay Therapeutics Inc (RLAY) is $10.17, with a high forecast of $19.95 and a low forecast of $0.382. This indicates an -41.44% decrease from the last price of $17.36.
Month Average Low High Change from today's price
January, 2027 $10.49 $9.4518 $17.73 -39.56%
February, 2027 $5.1252 $3.3035 $10.19 -70.48%
March, 2027 $4.8144 $3.9877 $9.0744 -72.27%
April, 2027 $14.47 $4.8552 $17.05 -16.66%
May, 2027 $8.4969 $7.3669 $19.95 -51.05%
June, 2027 $2.1003 $0.7303 $10.73 -87.90%
July, 2027 $0.9937 $0.382 $2.837 -94.28%
August, 2027 $4.4029 $0.6455 $7.7971 -74.64%
September, 2027 $5.8063 $2.6354 $8.8387 -66.55%
October, 2027 $10.24 $3.6121 $12.10 -41.02%
November, 2027 $7.5788 $6.6622 $18.30 -56.34%
December, 2027 $7.6622 $4.6505 $8.3164 -55.86%

Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2028

In 2028, Relay Therapeutics Inc (RLAY) is projected to reach an average price of $4.5602, with a high projection of $9.0357 and a low estimate of $0.0848. This indicates an -73.73% fall from the last price of $17.36.
Month Average Low High Change from today's price
January, 2028 $4.1514 $3.1397 $8.5081 -76.09%
February, 2028 $0.2748 $0.0848 $4.5731 -98.42%
March, 2028 $6.3582 $0.2994 $7.6423 -63.37%
April, 2028 $5.4415 $5.3115 $9.0357 -68.65%
May, 2028 $1.3407 $0.5007 $5.4732 -92.28%
June, 2028 $4.0841 $0.8533 $4.3441 -76.47%
July, 2028 $3.5067 $1.9899 $5.3699 -79.80%
August, 2028 $2.1833 $3.0233 $2.9358 -87.42%
September, 2028 $0.9899 $1.7899 $1.6275 -94.30%
October, 2028 $0.8207 $1.2507 $0.9966 -95.27%
November, 2028 $3.0474 $2.3849 $2.2974 -82.45%
December, 2028 $3.844 $2.9357 $2.884 -77.86%

Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2029

The 2029 price forecast for Relay Therapeutics Inc Stock (RLAY) is $4.0581 on average, with a high prediction of $6.3831 and a low estimate of $1.733. This represents an -76.62% decrease from the previous price of $17.36.
Month Average Low High Change from today's price
January, 2029 $6.3148 $4.8282 $5.3298 -63.62%
February, 2029 $5.3214 $5.6914 $6.3831 -69.35%
March, 2029 $4.1781 $5.0697 $4.1681 -75.93%
April, 2029 $1.2488 $1.7847 $3.3022 -92.81%
May, 2029 $3.3955 $1.733 $2.6855 -80.44%
June, 2029 $2.5421 $3.1821 $3.3488 -85.36%
July, 2029 $4.6229 $2.5004 $4.1029 -73.37%
August, 2029 $6.3495 $4.8871 $5.1503 -63.42%
September, 2029 $5.7862 $5.742 $5.7737 -66.67%
October, 2029 $4.767 $5.022 $5.2203 -72.54%
November, 2029 $3.7336 $5.6111 $5.4294 -78.49%
December, 2029 $5.1444 $3.5319 $4.4944 -70.37%

Relay Therapeutics Inc Stock (RLAY) Price Forecast for 2030

Relay Therapeutics Inc Stock (RLAY) is expected to reach an average price of $6.3929 in 2030, with a high forecast of $8.4165 and a low forecast of $4.3693. This signifies an -63.17% decrease from the last price of $17.36.
Month Average Low High Change from today's price
January, 2030 $5.501 $5.1568 $4.9485 -68.31%
February, 2030 $4.5576 $4.3693 $4.0676 -73.75%
March, 2030 $5.5143 $5.1001 $4.7643 -68.24%
April, 2030 $6.6551 $5.8067 $6.2201 -61.66%
May, 2030 $7.1417 $6.7792 $6.5434 -58.86%
June, 2030 $6.7483 $7.1042 $6.95 -61.13%
July, 2030 $7.0691 $6.7966 $6.8591 -59.28%
August, 2030 $7.3057 $7.1933 $7.3816 -57.92%
September, 2030 $8.4165 $7.8949 $8.4165 -51.52%
October, 2030 $7.4832 $7.5632 $8.0007 -56.89%
November, 2030 $7.6298 $7.8048 $7.5344 -56.05%
December, 2030 $7.0406 $7.2006 $7.159 -59.44%
$22.22
price down icon 8.07%
TLX TLX
$10.92
price down icon 3.28%
$36.28
price down icon 5.64%
$12.61
price down icon 0.20%
$17.88
price up icon 0.45%
$26.65
price down icon 5.96%
Cap:     |  Volume (24h):